The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

It also heralded a change in strategy, with CEO Robert Davis saying that the company is undergoing "a multiyear optimization ...

Investors soured on the sector when Elevance, an insurer, handed in disappointing results and shared a downbeat outlook.

A strong medical technology segment and an expanding pharmaceutical business could keep pushing ... Learn More » Image source ...

AM AWL Agri Business Ltd.(up 6.54%), Parag Milk Foods Ltd.(up 3.51%), ADF Foods Ltd.(up 3.18%), Dodla Dairy Ltd.(up 2.40%), ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Celcuity stock (NASDAQ: CELC), a clinical-stage biotechnology company, experienced an extraordinary 3x surge in a single ...

Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Clinical-stage biotech Recursion Pharmaceuticals ' (NASDAQ: RXRX) stock took it on the chin in the first trading day of the ...